5:53 PM
 | 
Oct 29, 2013
 |  BC Extra  |  Financial News

Gilead's 3Q13 earnings beat Street

Gilead Sciences Inc. (NASDAQ:GILD) reported 3Q13 non-GAAP diluted EPS of $0.52, beating the Street's estimate of $0.48 and up from $0.50 in 3Q12. Total revenues...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >